Aller au contenu principal
Profil bibliographique

Elizabeth Tyrrell-Bunge

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
12Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Eating Disorders and BehaviorsChild Nutrition and Feeding IssuesObesity, Physical Activity, DietCOVID-19 and Mental HealthImpact of Technology on Adolescents

Les publications récentes

Accès ouvert 2025 article OpenAlex

Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study

Ece Sengun Filiz, Dominic Stringer, Vanessa Kellermann, Rachel Rowan Olive et autres

Background: In clinical practice, olanzapine is commonly used in young people with anorexia nervosa, although the underpinning evidence-base is limited. However, its efficacy, tolerability, acceptability and adherence rate, and the patients', carers' and clinicians' views of olanzapine treatment are unclear. This synopsis …

gb, au (code pays fourni par la source)

0 citations Health Technology Assessment
Accès ouvert 2024 article OpenAlex

An update on the prevalence rates of disordered eating behaviours in children and adolescents with overweight or obesity and the management of binge eating disorder

Elizabeth Tyrrell-Bunge, Dasha Nicholls, Darren J. Cutinha

Background: A number of studies have been published in recent years examining disordered eating behaviours (DEBs) in children and young people (CYP). Objective: To provide an up-to-date review of prevalence rates across a range of DEBs, including food addiction, in CYP living …

gb (code pays fourni par la source)

0 citations Cutting Edge Psychiatry in Practice
Accès ouvert 2024 article OpenAlex

Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study

Olena Said, Dominic Stringer, Ece Sengun Filiz, Hiba Mutwalli et autres

Despite the availability of evidence-based treatments for anorexia nervosa (AN), remission rates are moderate, and mortality is high. Olanzapine is used as adjunct therapy for AN in case of insufficient response to first-line treatments, even though the evidence is limited. Its effect …

gb, sa, tr, au (code pays fourni par la source)

6 citations BMC Psychiatry

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.